BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2014

View Archived Issues

DuoGel designed for vaginal and rectal delivery of anti-HIV microbicides

Read More

Data from three phase I studies of QGE-031 reported

Read More

Repurposing of licensed therapeutic agents to treat human viral infections

Read More

Researchers at Novartis patent novel PI3K/mTOR inhibitors for cancer

Read More

Karus Therapeutics discloses new HDAC inhibitors

Read More

ImaginAb licenses PET imaging agents targeting murine T cells from UCLA

Read More

Bristol-Myers Squibb and Syngene extend collaboration in India

Read More

NanoString collaborates with Celgene on companion diagnostic test for Revlimid

Read More

Protalex reports new data analysis from phase Ib study of PRTX-100 for rheumatoid arthritis

Read More

FDA grants orphan drug status to two pancreatic cancer treatments

Read More

Bristol-Myers Squibb designs novel TYK2 inhibitors

Read More

Researchers at Merck & Co. disclose new SYK inhibitors

Read More

Scientists at Purdue Pharma patent new agents for pain and constipation

Read More

Array BioPharma's ARRY-797 receives FDA orphan drug status for DCM

Read More

ABT-414 plus temozolomide: preliminary efficacy results of a phase I study in glioblastoma

Read More

New phase II trial evaluation of PLX-3397 as a single agent in patients with recurrent glioblastoma

Read More

GlaxoSmithKline presents first-in-human results for GSK-2636771

Read More

microRNAs mir-21 and mir-221 overexpressed in placentas from patients with pre-eclampsia

Read More

NIH awards grant to Daktari Diagnostics to support development of HCV diagnostic

Read More

Study shows ivacaftor improves lung function in patients with CF

Read More

Kadmon confirms initiation of phase Ib/IIa study of KD-019 and trastuzumab

Read More

AFFiRiS reports encouraging data from phase II study of AD-04 in Alzheimer's disease

Read More

Enrollment open in Advanced Cancer Therapeutics' phase I study of PFK-158

Read More

FDA removes clinical hold on phase II study of PEGPH-20 for pancreatic cancer

Read More

Ocugen receives orphan designation for OCU-100 in retinitis pigmentosa

Read More

EMA validates MAA for Raxone in Leber's hereditary optic neuropathy

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing